We are live on ! Find out more
JCM

Jacobi Capital Management Portfolio holdings

AUM $2.04B
1-Year Est. Return 26.26%
This Fund
S&P 500
This Quarter Est. Return
-0.99%
1 Year Est. Return
+26.26%
3 Year Est. Return
+76.57%
5 Year Est. Return
+89.08%
10 Year Est. Return
+253.33%
AUM
$786M
AUM Growth
+$29.7M
Cap. Flow
+$40.9M
Cap. Flow %
5.21%
Top 10 Hldgs %
37.15%
Holding
1,525
New
118
Increased
538
Reduced
204
Closed
60
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNG icon
1501
United States Natural Gas Fund
UNG
$459M
$0 ﹤0.01%
1
VAL.WS icon
1502
Valaris Ltd Warrants
VAL.WS
$616M
$0 ﹤0.01%
1
VSS icon
1503
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.7B
-33
Closed -$4K
WTW icon
1504
Willis Towers Watson
WTW
$31.4B
-99
Closed -$23K
WWD icon
1505
Woodward
WWD
$22.2B
-101
Closed -$12K
CMRX
1506
DELISTED
Chimerix, Inc.
CMRX
$0 ﹤0.01%
65
LUMO
1507
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$0 ﹤0.01%
5
SLGCW
1508
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$0 ﹤0.01%
+40
New +$123
VRTV
1509
DELISTED
VERITIV CORPORATION
VRTV
$0 ﹤0.01%
1
AGRX
1510
DELISTED
Agile Therapeutics
AGRX
0
LHCG
1511
DELISTED
LHC Group LLC
LHCG
-60
Closed -$12K
OTIC
1512
DELISTED
Otonomy, Inc.
OTIC
-1,000
Closed -$2K
MGP
1513
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
$0 ﹤0.01%
4
-250
-98% -$9.79K
KDMN
1514
DELISTED
Kadmon Holdings, Inc.
KDMN
-200
Closed -$1.14K
CMIIU
1515
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
-200
Closed -$3K
CORE
1516
DELISTED
Core Mark Holding Co., Inc.
CORE
-754
Closed -$34K
PFPT
1517
DELISTED
Proofpoint, Inc.
PFPT
-300
Closed -$52K
MXIM
1518
DELISTED
Maxim Integrated Products
MXIM
-86
Closed -$9K
ALXN
1519
DELISTED
Alexion Pharmaceuticals
ALXN
-326
Closed -$60K
WORK
1520
DELISTED
Slack Technologies, Inc.
WORK
-353
Closed -$16K
HZNP
1521
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-181
Closed -$17K
NVIV
1522
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
0
ORBC
1523
DELISTED
ORBCOMM, Inc.
ORBC
-2,000
Closed -$22K
STMP
1524
DELISTED
Stamps.com, Inc.
STMP
-22
Closed -$4K
AIM
1525
AIM ImmunoTech
AIM
$7.71M
0

Similar funds

Jacobi Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Jacobi Capital Management held 1,525 positions worth $786M, up 3.9% from $757M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Jacobi Capital Management deployed $40.9M of net new capital in Q3 2021, opening 118 new positions and adding to 538 existing holdings. Its largest new stake was Fidelity D&D Bancorp: 24,540 shares worth $1.24M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street SPDR Portfolio Emerging Markets ETF, an estimated $7.27M trimmed.

  • Jacobi Capital Management's largest Q3 2021 buy was Fidelity D&D Bancorp: 24,540 shares worth $1.24M.
  • Jacobi Capital Management added most to Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF in Q3 2021, an estimated $7.47M increase.
  • Jacobi Capital Management's biggest Q3 2021 reduction was State Street SPDR Portfolio Emerging Markets ETF, cutting an estimated $7.27M.
  • Jacobi Capital Management fully exited iShares MSCI China ETF in Q3 2021, selling an estimated $66K.
  • Jacobi Capital Management's ten largest holdings make up 37% of its $786M portfolio in Q3 2021.
  • Jacobi Capital Management opened 118 new positions and closed 60 in Q3 2021.
  • Jacobi Capital Management's portfolio value rose 3.9% quarter-over-quarter to $786M.

Based on Jacobi Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.